Drug Patents owned by Aquestive

1. Drug name - SYMPAZAN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765167 AQUESTIVE Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions Feb, 2024

(1 year, 4 months from now)

US8603514 AQUESTIVE Uniform films for rapid dissolve dosage form incorporating taste-masking compositions Apr, 2024

(1 year, 5 months from now)

More Information on Dosage
Strength Dosage Availability
5MG FILM;ORAL Prescription
10MG FILM;ORAL Prescription
20MG FILM;ORAL Prescription

2. Drug name - ZUPLENZ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8580830 AQUESTIVE Non-mucoadhesive film dosage forms Nov, 2029

(7 years from now)

US9095577 AQUESTIVE Stabilized amine-containing actives in oral film compositions Jul, 2030

(7 years from now)

More Information on Dosage
Strength Dosage Availability
4MG FILM;ORAL Discontinued
8MG FILM;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.